Li, Jianke <br/><br/>
Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients.  [electronic resource] 

 -  Current medical research and opinion  Aug 2010 
 - 2003-10 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/03007995.2010.491266  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Boronic Acids--administration & dosage<br/>Cross-Over Studies<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptidyl Peptidase 4<br/>Dipeptidyl-Peptidase IV Inhibitors--administration & dosage<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Male<br/>Metformin--administration & dosage<br/>Middle Aged